Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	40	non-cytoplasmic
41	60	transmembrane
61	93	cytoplasmic
94	120	transmembrane
121	125	non-cytoplasmic
126	145	transmembrane
146	157	cytoplasmic
158	178	transmembrane
179	201	non-cytoplasmic
202	222	transmembrane
223	233	cytoplasmic
234	256	transmembrane
257	281	non-cytoplasmic
282	310	transmembrane
311	330	cytoplasmic
331	352	transmembrane
353	357	non-cytoplasmic
358	380	transmembrane
381	394	cytoplasmic
395	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	448	cytoplasmic
449	469	transmembrane
470	475	non-cytoplasmic

Input:
>GFF4359 FitnessBrowser__WCS417:GFF4359
MSQPAQKLRLSALIALVVGSMIGGGIFSLPQNMAARAEVGAVLIGWAITAVGMLTLAFVF
QTLANRKPELDSGVYAYAKAGFGDYMGFSSAWGYWISAWMGNVGYFVLLFSTLGYFFPIF
GQGNTPVAIGCASLLLWAVHFLVLRGIKEAAFINQITTVAKIVPLLMFIVIAGVAFKAEI
FTRDIWGVGNPNMGNVVDQVRNMMLVTVFVFIGIEGASVYSARAEKRSDVGRATVIGFLG
VLALLVLVNVLSLGIMSQPQLAQLQNPSLAGVLEHIVGPWGAMAISIGLAVSLLGALLSW
ALLCAEILYATAHDKTMPAFLKKENANQVPVNALWLTNVMIQVFLVITLFSHSTYTTLIY
LASSMILVPYLWSAAYAVLLSGRGETYQGAHGQRIKDLLVGLIALGYAVWLLYAGGLKYL
LLSALLYAPGVILFALAKREQDQPLFTHVEKGIFSCVIAGAGLAAYGLYSGVLSL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server